Clinical Pharmacology Studies. Phase 1.
Abstract
The scientific work of this year centered around (1) The pharmacokinetics and pharmacodynamics of a low dose eight-hour intravenous infusion of pyridostigmine and (2) The bioava, safety, tolerance, pharmacokinetics and pharmacodynamics of two sustained release formulations of pyridostigmine compared to pyridostigmine syrup. The clinical portion of these two studies were designed in the second year under the provisions of Task Order 6. These protocols have been approved by the Johns Hopkins institutional review board and submitted for review by the Human Subjects Research Review Board. We anticipate that they will be initiated early in the third year of the contract. (kt)
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 17, 1988
- Accession Number
- ADB130072
Entities
People
- Brent G. Petty
- David M. Kornhauser
- Paul S. Lietman
Organizations
- Johns Hopkins University